Those on placebo showed a trend towards less prolonged viral shedding (<9 days) and it was observed that all antipyretic groups had significantly higher nasal obstruction and nasal turbinate swelling relative to placebo.
1
—
—
Those on placebo showed a trend towards less prolonged viral shedding (<9 days) and it was observed that all antipyretic groups had significantly higher nasal obstruction and nasal turbinate swelling relative to placebo.